The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Coglapix suspension for injection for pigs.

Ceva Santé AnimaleVPA10815/030/001

Main Information

Trade NameCoglapix suspension for injection for pigs.
Active SubstancesActinobacillus pleuropneumoniae strain nt3
Actinobacillus pleurpneumoniae strain szii
Actinobacillus pleuropneumoniae strain po
Actinobacillus pleuropneumoniae strain u3
Actinobacillus pleuropneumoniae strain b4
Dosage FormSuspension for injection
Licence HolderCeva Santé Animale
License Holder Address10, avenue de La Ballastière
33500 Libourne
Licence NumberVPA10815/030/001

Group Information

ATC CodeQI09AB07 actinobacillus/haemophilus vaccine
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued23/10/2015
Legal StatusPOM (E): Prescription Only Exempt as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back